Pauls Dietrich John 4
4 · DiaMedica Therapeutics Inc. · Filed Aug 16, 2019
Insider Transaction Report
Form 4
Pauls Dietrich John
DirectorPresident & CEO
Transactions
- Purchase
Voting Common Shares, no par value per share
2019-08-16$2.68/sh+1,000$2,677→ 30,804 total
Footnotes (1)
- [F1]Includes 1,749 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan.